News

Vijaya Diagnostic Centre announced that the Board of Directors of the Company at its meeting held on 7 May 2026, inter alia, have recommended the final dividend of Rs 2 per equity Share (i.e. 200%) , subject to the approval of the shareholders.

Net profit of Vijaya Diagnostic Centre rose 37.49% to Rs 47.93 crore in the quarter ended March 2026 as against Rs 34.86 crore during the previous quarter ended March 2025. Sales rose 26.63% to Rs 219.38 crore in the quarter ended March 2026 as against Rs 173.24 crore during the previous quarter ended March 2025.For the full year,net profit rose 20.30% to Rs 172.98 crore in the year ended March 2026 as against Rs 143.79 crore during the previous year ended March 2025. Sales rose 19.49% to Rs 814.20 crore in the year ended March 2026 as against Rs 681.39 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales219.38173.24 27 814.20681.39 19 OPM %43.5439.75 -41.3840.10 - PBDT88.6067.22 32 324.50264.79 23 PBT64.2748.40 33 232.68194.19 20 NP47.9334.86 37 172.98143.79 20 Powered by Capital Market - Live News

Vijaya Diagnostic Centre will hold a meeting of the Board of Directors of the Company on 7 May 2026.

Net profit of Vijaya Diagnostic Centre rose 22.81% to Rs 43.18 crore in the quarter ended December 2025 as against Rs 35.16 crore during the previous quarter ended December 2024. Sales rose 21.44% to Rs 205.21 crore in the quarter ended December 2025 as against Rs 168.98 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales205.21168.98 21 OPM %41.9439.73 - PBDT82.5665.01 27 PBT58.2246.70 25 NP43.1835.16 23 Powered by Capital Market - Live News

Vijaya Diagnostic Centre will hold a meeting of the Board of Directors of the Company on 13 February 2026.Powered by Capital Market - Live News